<br />
eXPeRT OPINION<br />
Newfoundland’s pick for CMA chief<br />
Pharmacare, rural issues and system reform<br />
top Haggie’s agenda<br />
<br />
■ by Sam Solomon<br />
<br />
<br />
DR. JOHN HAGGIe, a vascular and general<br />
surgeon from Gander, has been elected as<br />
Newfoundland and Labrador’s pick for the<br />
2011-12 presidency of the Canadian Medical<br />
Association, pending confirmation this August.<br />
Dr. Haggie, who immigrated in 1996 from<br />
his native England, served as president of<br />
<br />
<br />
INTeRVIeW<br />
<br />
his province’s medical association in 2002-3,<br />
when the province’s physicians, in their only<br />
strike ever, withdrew all services except for<br />
emergency care until an arbitrator awarded the<br />
doctor’s union a new<a title="PE July-August 2010 2010-n18v7.pdf page 1" href="http://viewer.zmags.com/publication/29a87a23?page=1">Bipolar disorder nervous </a> Bipolar disorder nervous <a title="PE July-August 2010 2010-n18v7.pdf page 2" href="http://viewer.zmags.com/publication/29a87a23?page=2">CRESTOR is also indicated as an adjunct to diet, </a> CRESTOR is also indicated as an adjunct to diet, <a title="PE July-August 2010 2010-n18v7.pdf page 3" href="http://viewer.zmags.com/publication/29a87a23?page=3">In adult patients without documented history of c</a> In adult patients without documented history of c<a title="PE July-August 2010 2010-n18v7.pdf page 4" href="http://viewer.zmags.com/publication/29a87a23?page=4">Introducing OnglyzaTM 5 mg For your patient</a> Introducing OnglyzaTM 5 mg For your patient<a title="PE July-August 2010 2010-n18v7.pdf page 5" href="http://viewer.zmags.com/publication/29a87a23?page=5">CONTeNTSJuly/August 20101PHOTOS, FACTS AND</a> CONTeNTSJuly/August 20101PHOTOS, FACTS AND<a title="PE July-August 2010 2010-n18v7.pdf page 6" href="http://viewer.zmags.com/publication/29a87a23?page=6"></a> <a title="PE July-August 2010 2010-n18v7.pdf page 7" href="http://viewer.zmags.com/publication/29a87a23?page=7">CONTeNTSJuly/August 201040 CARDIOLOGY </a> CONTeNTSJuly/August 201040 CARDIOLOGY <a title="PE July-August 2010 2010-n18v7.pdf page 8" href="http://viewer.zmags.com/publication/29a87a23?page=8">Help your patientsget antifungal relief fastwi</a> Help your patientsget antifungal relief fastwi<a title="PE July-August 2010 2010-n18v7.pdf page 9" href="http://viewer.zmags.com/publication/29a87a23?page=9">eDITORIALBiomedical engineeringPICTURe THIS</a> eDITORIALBiomedical engineeringPICTURe THIS<a title="PE July-August 2010 2010-n18v7.pdf page 10" href="http://viewer.zmags.com/publication/29a87a23?page=10">parkhurst exchangeEDITORSOwen DyerMilena Kat</a> parkhurst exchangeEDITORSOwen DyerMilena Kat<a title="PE July-August 2010 2010-n18v7.pdf page 11" href="http://viewer.zmags.com/publication/29a87a23?page=11"> Anxiety is recognized as a disorder by dis-</a> Anxiety is recognized as a disorder by dis-<a title="PE July-August 2010 2010-n18v7.pdf page 12" href="http://viewer.zmags.com/publication/29a87a23?page=12">Startwith ARICEPT®for efficacy in mild, moderat</a> Startwith ARICEPT®for efficacy in mild, moderat<a title="PE July-August 2010 2010-n18v7.pdf page 13" href="http://viewer.zmags.com/publication/29a87a23?page=13">DIAGNOSTIC CHALLeNGeMexican standoffWhat’s mak</a> DIAGNOSTIC CHALLeNGeMexican standoffWhat’s mak<a title="PE July-August 2010 2010-n18v7.pdf page 14" href="http://viewer.zmags.com/publication/29a87a23?page=14">Say good morningwithTECTA® andhelp say good nig</a> Say good morningwithTECTA® andhelp say good nig<a title="PE July-August 2010 2010-n18v7.pdf page 15" href="http://viewer.zmags.com/publication/29a87a23?page=15">5-MINUTeS on diseases of the aortaTreat growin</a> 5-MINUTeS on diseases of the aortaTreat growin<a title="PE July-August 2010 2010-n18v7.pdf page 16" href="http://viewer.zmags.com/publication/29a87a23?page=16">DIAGNOSTIC CHALLeNGe ANSWeRTrigeminal neuralgia</a> DIAGNOSTIC CHALLeNGe ANSWeRTrigeminal neuralgia<a title="PE July-August 2010 2010-n18v7.pdf page 17" href="http://viewer.zmags.com/publication/29a87a23?page=17">10 things you should know about…Neurological ex</a> 10 things you should know about…Neurological ex<a title="PE July-August 2010 2010-n18v7.pdf page 18" href="http://viewer.zmags.com/publication/29a87a23?page=18">Pe PanelAllergyAmin S. kanani MD FRCPCClinica</a> Pe PanelAllergyAmin S. kanani MD FRCPCClinica<a title="PE July-August 2010 2010-n18v7.pdf page 19" href="http://viewer.zmags.com/publication/29a87a23?page=19">Q&AA forum of exchange for questions, ideasand </a> Q&AA forum of exchange for questions, ideasand <a title="PE July-August 2010 2010-n18v7.pdf page 20" href="http://viewer.zmags.com/publication/29a87a23?page=20">Q&APlumbing problemWhy do postmenopausal pat</a> Q&APlumbing problemWhy do postmenopausal pat<a title="PE July-August 2010 2010-n18v7.pdf page 21" href="http://viewer.zmags.com/publication/29a87a23?page=21">The Mamas and the PAPP-AsWhat’s the significance</a> The Mamas and the PAPP-AsWhat’s the significance<a title="PE July-August 2010 2010-n18v7.pdf page 22" href="http://viewer.zmags.com/publication/29a87a23?page=22">Q&AEndometrial screening on ta-moxifen: not</a> Q&AEndometrial screening on ta-moxifen: not<a title="PE July-August 2010 2010-n18v7.pdf page 23" href="http://viewer.zmags.com/publication/29a87a23?page=23">10miliondosesdistributedinover 100countries.1On</a> 10miliondosesdistributedinover 100countries.1On<a title="PE July-August 2010 2010-n18v7.pdf page 24" href="http://viewer.zmags.com/publication/29a87a23?page=24">Q&AThe PD bluesDepression and Parkinson’s di</a> Q&AThe PD bluesDepression and Parkinson’s di<a title="PE July-August 2010 2010-n18v7.pdf page 25" href="http://viewer.zmags.com/publication/29a87a23?page=25">Ease off on the final stretch?I look after a num</a> Ease off on the final stretch?I look after a num<a title="PE July-August 2010 2010-n18v7.pdf page 26" href="http://viewer.zmags.com/publication/29a87a23?page=26">Q&ANew study, same old drugIs there any new </a> Q&ANew study, same old drugIs there any new <a title="PE July-August 2010 2010-n18v7.pdf page 27" href="http://viewer.zmags.com/publication/29a87a23?page=27">The A-teamIs there a benefit to treating symptom</a> The A-teamIs there a benefit to treating symptom<a title="PE July-August 2010 2010-n18v7.pdf page 28" href="http://viewer.zmags.com/publication/29a87a23?page=28">Q&AFinger-pricking goodWhat do the experts </a> Q&AFinger-pricking goodWhat do the experts <a title="PE July-August 2010 2010-n18v7.pdf page 29" href="http://viewer.zmags.com/publication/29a87a23?page=29">Distinguishing marksHow can we differentiate pla</a> Distinguishing marksHow can we differentiate pla<a title="PE July-August 2010 2010-n18v7.pdf page 30" href="http://viewer.zmags.com/publication/29a87a23?page=30">Q&ASmall meningiomas unlikelyto cause sympt</a> Q&ASmall meningiomas unlikelyto cause sympt<a title="PE July-August 2010 2010-n18v7.pdf page 31" href="http://viewer.zmags.com/publication/29a87a23?page=31"> The colour of reliefin major depressiv</a> The colour of reliefin major depressiv<a title="PE July-August 2010 2010-n18v7.pdf page 32" href="http://viewer.zmags.com/publication/29a87a23?page=32">Q&AFollowing polycythemiaI had two consecuti</a> Q&AFollowing polycythemiaI had two consecuti<a title="PE July-August 2010 2010-n18v7.pdf page 33" href="http://viewer.zmags.com/publication/29a87a23?page=33">Question ofthe monthA PET is not a toyDuring</a> Question ofthe monthA PET is not a toyDuring<a title="PE July-August 2010 2010-n18v7.pdf page 34" href="http://viewer.zmags.com/publication/29a87a23?page=34">Q&ANifedipine in Raynaud’sIs tadalafil super</a> Q&ANifedipine in Raynaud’sIs tadalafil super<a title="PE July-August 2010 2010-n18v7.pdf page 35" href="http://viewer.zmags.com/publication/29a87a23?page=35">PRACTICe MANAGeMeNTPatients who complainShould</a> PRACTICe MANAGeMeNTPatients who complainShould<a title="PE July-August 2010 2010-n18v7.pdf page 36" href="http://viewer.zmags.com/publication/29a87a23?page=36">DeRMATOLOGYLichen sclerosisA troublesome condi</a> DeRMATOLOGYLichen sclerosisA troublesome condi<a title="PE July-August 2010 2010-n18v7.pdf page 37" href="http://viewer.zmags.com/publication/29a87a23?page=37">Help treatyour patients' acne fastwith </a> Help treatyour patients' acne fastwith <a title="PE July-August 2010 2010-n18v7.pdf page 38" href="http://viewer.zmags.com/publication/29a87a23?page=38">DeRMATOLOGYDiagnosisA biopsy of the affect</a> DeRMATOLOGYDiagnosisA biopsy of the affect<a title="PE July-August 2010 2010-n18v7.pdf page 39" href="http://viewer.zmags.com/publication/29a87a23?page=39">PeDIATRICSWhen they stop breathingChildren do </a> PeDIATRICSWhen they stop breathingChildren do <a title="PE July-August 2010 2010-n18v7.pdf page 40" href="http://viewer.zmags.com/publication/29a87a23?page=40">CARDIOLOGYDiuretics: in the loopLatest data fa</a> CARDIOLOGYDiuretics: in the loopLatest data fa<a title="PE July-August 2010 2010-n18v7.pdf page 41" href="http://viewer.zmags.com/publication/29a87a23?page=41">ANEWANDEFFECTIVEDIETARYAPPROACHTOLOWERING </a> ANEWANDEFFECTIVEDIETARYAPPROACHTOLOWERING <a title="PE July-August 2010 2010-n18v7.pdf page 42" href="http://viewer.zmags.com/publication/29a87a23?page=42"> ADVERTORIALPLANTSTEROLS–CLINICALOVER</a> ADVERTORIALPLANTSTEROLS–CLINICALOVER<a title="PE July-August 2010 2010-n18v7.pdf page 43" href="http://viewer.zmags.com/publication/29a87a23?page=43">CARDIOLOGYDIUReTICS: IN THe LOOPContinued from </a> CARDIOLOGYDIUReTICS: IN THe LOOPContinued from <a title="PE July-August 2010 2010-n18v7.pdf page 44" href="http://viewer.zmags.com/publication/29a87a23?page=44">eXPeRT OPINIONNewfoundland’s pick for CMA chief</a> eXPeRT OPINIONNewfoundland’s pick for CMA chief<a title="PE July-August 2010 2010-n18v7.pdf page 45" href="http://viewer.zmags.com/publication/29a87a23?page=45">HeAD CASeNew evidence on the pharmacotherapyof</a> HeAD CASeNew evidence on the pharmacotherapyof<a title="PE July-August 2010 2010-n18v7.pdf page 46" href="http://viewer.zmags.com/publication/29a87a23?page=46">PeRSPeCTIVeS ON PAINPlatelet-rich plasma inject</a> PeRSPeCTIVeS ON PAINPlatelet-rich plasma inject<a title="PE July-August 2010 2010-n18v7.pdf page 47" href="http://viewer.zmags.com/publication/29a87a23?page=47">in PRP are vitronectin, fibronectin and fibrin,a</a> in PRP are vitronectin, fibronectin and fibrin,a<a title="PE July-August 2010 2010-n18v7.pdf page 48" href="http://viewer.zmags.com/publication/29a87a23?page=48">New to Canada!</a> New to Canada!<a title="PE July-August 2010 2010-n18v7.pdf page 49" href="http://viewer.zmags.com/publication/29a87a23?page=49">New BuTrans 7-day patch:Introducing a new course</a> New BuTrans 7-day patch:Introducing a new course<a title="PE July-August 2010 2010-n18v7.pdf page 50" href="http://viewer.zmags.com/publication/29a87a23?page=50">(p < 0.001). The corticosteroid group wasbetter </a> (p < 0.001). The corticosteroid group wasbetter <a title="PE July-August 2010 2010-n18v7.pdf page 51" href="http://viewer.zmags.com/publication/29a87a23?page=51">Factors that may impaircollagen synthesis andte</a> Factors that may impaircollagen synthesis andte<a title="PE July-August 2010 2010-n18v7.pdf page 52" href="http://viewer.zmags.com/publication/29a87a23?page=52">MelanomaPrimary care is the place to stop itby</a> MelanomaPrimary care is the place to stop itby<a title="PE July-August 2010 2010-n18v7.pdf page 53" href="http://viewer.zmags.com/publication/29a87a23?page=53"> These abnormalities promote cell prolif-era</a> These abnormalities promote cell prolif-era<a title="PE July-August 2010 2010-n18v7.pdf page 54" href="http://viewer.zmags.com/publication/29a87a23?page=54"> Mohs micrographic surgery has also beenpro</a> Mohs micrographic surgery has also beenpro<a title="PE July-August 2010 2010-n18v7.pdf page 55" href="http://viewer.zmags.com/publication/29a87a23?page=55"> Treatment of patients with advanced-stageme</a> Treatment of patients with advanced-stageme<a title="PE July-August 2010 2010-n18v7.pdf page 56" href="http://viewer.zmags.com/publication/29a87a23?page=56"> A new or changing mole orblemish is t</a> A new or changing mole orblemish is t<a title="PE July-August 2010 2010-n18v7.pdf page 57" href="http://viewer.zmags.com/publication/29a87a23?page=57">(as saxagliptin hydrochloride)Tablets, 5 mgOral</a> (as saxagliptin hydrochloride)Tablets, 5 mgOral<a title="PE July-August 2010 2010-n18v7.pdf page 58" href="http://viewer.zmags.com/publication/29a87a23?page=58">Supplemental Product InformationADVERSE REACTIO</a> Supplemental Product InformationADVERSE REACTIO<a title="PE July-August 2010 2010-n18v7.pdf page 59" href="http://viewer.zmags.com/publication/29a87a23?page=59">Diltiazem: Coadministration of a single dose of s</a> Diltiazem: Coadministration of a single dose of s<a title="PE July-August 2010 2010-n18v7.pdf page 60" href="http://viewer.zmags.com/publication/29a87a23?page=60"> </a> <a title="PE July-August 2010 2010-n18v7.pdf page 61" href="http://viewer.zmags.com/publication/29a87a23?page=61">Prior to dispensing, tap the vial until powder fl</a> Prior to dispensing, tap the vial until powder fl<a title="PE July-August 2010 2010-n18v7.pdf page 62" href="http://viewer.zmags.com/publication/29a87a23?page=62">10 mg and 20 mg tabletsPrescribing SummaryPati</a> 10 mg and 20 mg tabletsPrescribing SummaryPati<a title="PE July-August 2010 2010-n18v7.pdf page 63" href="http://viewer.zmags.com/publication/29a87a23?page=63">(NMS)-like events). Concomitant use of Cipralex® </a> (NMS)-like events). Concomitant use of Cipralex® <a title="PE July-August 2010 2010-n18v7.pdf page 64" href="http://viewer.zmags.com/publication/29a87a23?page=64"> Prescribing SummarySee prescribing summary on</a> Prescribing SummarySee prescribing summary on<a title="PE July-August 2010 2010-n18v7.pdf page 65" href="http://viewer.zmags.com/publication/29a87a23?page=65">REFLUX ESOPHAGITISThe recommended adult oral </a> REFLUX ESOPHAGITISThe recommended adult oral <a title="PE July-August 2010 2010-n18v7.pdf page 66" href="http://viewer.zmags.com/publication/29a87a23?page=66">Suspension for injectionActive immunizing agent</a> Suspension for injectionActive immunizing agent<a title="PE July-August 2010 2010-n18v7.pdf page 67" href="http://viewer.zmags.com/publication/29a87a23?page=67">Any unused product or waste material should be di</a> Any unused product or waste material should be di<a title="PE July-August 2010 2010-n18v7.pdf page 68" href="http://viewer.zmags.com/publication/29a87a23?page=68">(sitagliptin phosphate monohydrate) </a> (sitagliptin phosphate monohydrate) <a title="PE July-August 2010 2010-n18v7.pdf page 69" href="http://viewer.zmags.com/publication/29a87a23?page=69">Physicians should instruct their patients to reco</a> Physicians should instruct their patients to reco<a title="PE July-August 2010 2010-n18v7.pdf page 70" href="http://viewer.zmags.com/publication/29a87a23?page=70">For patients who have been stabilized on metformi</a> For patients who have been stabilized on metformi<a title="PE July-August 2010 2010-n18v7.pdf page 71" href="http://viewer.zmags.com/publication/29a87a23?page=71">JANUMET™: The starting dose of JANUMET™ shouldbe</a> JANUMET™: The starting dose of JANUMET™ shouldbe<a title="PE July-August 2010 2010-n18v7.pdf page 72" href="http://viewer.zmags.com/publication/29a87a23?page=72">Prescribing Summary Patient Selection </a> Prescribing Summary Patient Selection <a title="PE July-August 2010 2010-n18v7.pdf page 73" href="http://viewer.zmags.com/publication/29a87a23?page=73">Adverse Events Reported as Reasons for Discontinu</a> Adverse Events Reported as Reasons for Discontinu<a title="PE July-August 2010 2010-n18v7.pdf page 74" href="http://viewer.zmags.com/publication/29a87a23?page=74">SEXUAL FUNCTION ADVERSE REACTIONSTable 3 shows t</a> SEXUAL FUNCTION ADVERSE REACTIONSTable 3 shows t<a title="PE July-August 2010 2010-n18v7.pdf page 75" href="http://viewer.zmags.com/publication/29a87a23?page=75">Loprox® 6WXG\5HIHUHQFH3UHV</a> Loprox® 6WXG\5HIHUHQFH3UHV<a title="PE July-August 2010 2010-n18v7.pdf page 76" href="http://viewer.zmags.com/publication/29a87a23?page=76">Buprenorphine transdermal delivery systemPrescri</a> Buprenorphine transdermal delivery systemPrescri<a title="PE July-August 2010 2010-n18v7.pdf page 77" href="http://viewer.zmags.com/publication/29a87a23?page=77">not be used in patients who may be particularly s</a> not be used in patients who may be particularly s<a title="PE July-August 2010 2010-n18v7.pdf page 78" href="http://viewer.zmags.com/publication/29a87a23?page=78">siteerythema:7.1/1.5;applicationsitepain:1.5/0.8;</a> siteerythema:7.1/1.5;applicationsitepain:1.5/0.8;<a title="PE July-August 2010 2010-n18v7.pdf page 79" href="http://viewer.zmags.com/publication/29a87a23?page=79">adjustment generally separated by 7 days. The dos</a> adjustment generally separated by 7 days. The dos<a title="PE July-August 2010 2010-n18v7.pdf page 80" href="http://viewer.zmags.com/publication/29a87a23?page=80">Prescribing SummaryPatient Selection CriteriaTH</a> Prescribing SummaryPatient Selection CriteriaTH<a title="PE July-August 2010 2010-n18v7.pdf page 81" href="http://viewer.zmags.com/publication/29a87a23?page=81">generally transient and it decreased or disappear</a> generally transient and it decreased or disappear<a title="PE July-August 2010 2010-n18v7.pdf page 82" href="http://viewer.zmags.com/publication/29a87a23?page=82">do not achieve their target treatment on 20 mg an</a> do not achieve their target treatment on 20 mg an<a title="PE July-August 2010 2010-n18v7.pdf page 83" href="http://viewer.zmags.com/publication/29a87a23?page=83">Proper nameEffect </a> Proper nameEffect <a title="PE July-August 2010 2010-n18v7.pdf page 84" href="http://viewer.zmags.com/publication/29a87a23?page=84">Prescribing SummaryPatient Selection CriteriaT</a> Prescribing SummaryPatient Selection CriteriaT<a title="PE July-August 2010 2010-n18v7.pdf page 85" href="http://viewer.zmags.com/publication/29a87a23?page=85">receiving 10 mg/day and twice the placebo rate, a</a> receiving 10 mg/day and twice the placebo rate, a<a title="PE July-August 2010 2010-n18v7.pdf page 86" href="http://viewer.zmags.com/publication/29a87a23?page=86">Table 3. Mild-to-moderate Alzheimer’s disease: Ad</a> Table 3. Mild-to-moderate Alzheimer’s disease: Ad<a title="PE July-August 2010 2010-n18v7.pdf page 87" href="http://viewer.zmags.com/publication/29a87a23?page=87">SOLUTION TO ANALYZE THIS!For case description, s</a> SOLUTION TO ANALYZE THIS!For case description, s<a title="PE July-August 2010 2010-n18v7.pdf page 88" href="http://viewer.zmags.com/publication/29a87a23?page=88">ANALYZe THIS!What’s the cause of this man’svis</a> ANALYZe THIS!What’s the cause of this man’svis<a title="PE July-August 2010 2010-n18v7.pdf page 89" href="http://viewer.zmags.com/publication/29a87a23?page=89">Introducing Medflicksan organized video sharing s</a> Introducing Medflicksan organized video sharing s<a title="PE July-August 2010 2010-n18v7.pdf page 90" href="http://viewer.zmags.com/publication/29a87a23?page=90">Recommended as a First-LineAdd-On to Metformin1</a> Recommended as a First-LineAdd-On to Metformin1